Abstract: A cap is described for connection to a needleless connector having an open lumen, the cap includes a housing having a top wall and sidewall forming a first cavity, a flexible container, an porous absorbent material and a sealing rubber. The flexible container includes an inner thread on an inner surface, the inner thread being sufficient to interlock with a mating feature of a female needleless connector. The inner surface of the flexible container defines a second cavity. The sidewall of the housing having a split-thread protrusion integrally formed with the distal wall, an outer thread disposed on an outer surface of the split-thread protrusion, the outer thread being sufficient to interlock with a mating feature of a male needleless connector. The second cavity configured to define a chamber to contain an absorbent reservoir material, a sealing rubber and disinfectant or antimicrobial agent.

Abstract: The present invention relates to an oral care composition comprising a fructanase, use of said composition as medicaments, use of said composition in treatment of oral disease, methods of treatment comprising administering said composition to a human or animal subject, methods of removing biofilm comprising contacting the biofilm with said composition, kits of parts comprising said composition, and fructanases.

Abstract: Methods and systems herein relate to unmanned aerial vehicles (UAVs) avoiding collisions by interacting with servers. Some embodiments of a method include receiving, by an unmanned aircraft system (UAS) traffic management (UTM) server one or more intended trajectories from one or more UAVs; determining, by the UTM server one or more conflicts based on the intended trajectories intersecting over a region monitored by the UTM server; and communicating, by the UTM server the one or more conflicts, the communicating includes assigning a value to each of a plurality of three-dimensional (3D) grid cells representing the region monitored by the UTM server, each value representative of a potential for conflict associated with a grid cell; and transmitting, to the one or more UAVs, value data associated with the plurality of grid cells.

Abstract: A method includes rotating a wafer, dispensing a liquid from a center of the wafer to an edge of the wafer to control a temperature of the wafer, and etching an etch layer of the wafer with an etchant during or after dispensing the liquid. The liquid is dispensed through a nozzle.

Abstract: A device for connection to a female medical connector is disclosed, the device includes a cap, a scrubbing foam, an elastic sealing lip, and an absorbent material. The cap is configured to define a chamber to contain an absorbent material and disinfectant or antimicrobial agent. The cap may include one or more threads adapted to engage with a female luer connector. The device may also include a peelable seal to maintain sterility prior to use and to prevent the disinfectant or the antimicrobial agent from exiting the chamber prior to use. Also described are methods of disinfecting a medical connector.

Abstract: Systems, computer program products, and methods are described herein for secure resource allocation communication with a network. The present invention may be configured to provide, to a device management system, a request for authentication and receive, from the device management system, a file including a link to a certificate system. The present invention may be further configured to provide, using the link, a certificate enrollment request to the certificate system and receive, from the certificate system, a signed certificate. The present invention may be further configured to establish, using the signed certificate, a wireless connection to a network. In some embodiments, the present invention may include a scanner device for processing instruments associated with resource allocations and a network device communicatively connected to the scanner device for enabling the scanner device to communicate wirelessly with the network.

Abstract: Fluid applicators with precise volume dispensing control for dispensing fluids such as a disinfectant in a controlled manner are described herein. Such fluid applicators may include a barrel including a sidewall having an inside surface defining a chamber for retaining a fluid, an end press, a push rod disposed within the chamber, the push rod having a push button and a piercing tip, a cap attached to a port via a hinge to cover a hydrophobic filter disposed on the sidewall of the chamber, a one-way valve disposed on the outlet on a distal end of the barrel, a disinfectant disposed within the chamber; a housing having a base and an open proximal end; and a fluid applicator sponge disposed in the base of the housing. An alternate fluid may include a deformable end press, a plurality of volume scale markings on an outer surface of the barrel, a push rod, a one-way valve and applicator sponge.

Abstract: A disinfection cap for a male medical connector comprising a housing, a scrubbing foam having a plurality of slits disposed within a first cavity of the housing, a central post extending from the closed bottom of the housing and positioned within the first cavity of the housing, a foam jacket disposed on the central post and having a plurality of slits; and a central plug disposed in the center of the central post extending from the top wall of the central post and extending into the second cavity of the foam jacket. The inner surface of the foam jacket defines a second cavity.

Abstract: An OSS generates second identification information from first identification information, and generates setting information of a low power base station device based on the second identification information while reflecting position information. When verification of the first identification information is successful, the OSS transmits third identification information of a security GW and fourth identification information of an EMS to the low power base station device. The EMS receives a power on notification from the low power base station device via an IPsec tunnel established at the security GW. The OSS identifies the second identification information from the first identification information included in the power on notification, and writes the setting information identified from the second identification information to the low power base station device.

Abstract: The present disclosure describes membrane compositions and methods for preparing membrane compositions. In particular, the methods employ a layer-by-layer approach to membrane preparation. The membrane compositions provide significantly enhanced membrane performance over existing commercial membranes, particularly in terms of permeability and selectivity.

Abstract: Examples described herein include systems and methods for providing secure access to an email server. A gateway server can receive a request for email notification information from a notification server and parse the request to identify at least one user device associated with the request. The gateway server can then determine whether the identified devices comply with any applicable compliance rules, for example by requesting a compliance status from a management server at which the identified devices are enrolled. If at least one of the identified devices is in compliance, the gateway can pass the request through to the email server. The gateway can then receive a response from the email server and provide it to the notification server.

Abstract: This disclosure relates to pharmaceutical compositions in the form of a solution for oral delivery. Particularly, the pharmaceutical compositions comprise an active pharmaceutical ingredient, a buffering agent, and water. In some embodiments, the pH of the composition is from about pH 5 to about pH 8. In some embodiments, the active pharmaceutical ingredient is selected from ramipril, solifenacin, vigabatrin, losartan potassium, warfarin, and melatonin.

Abstract: Discussed herein are pharmaceutical compositions containing Ibrutinib and processes for preparing them. The compositions may be utilized in the treatment of a variety of conditions including, without limitation, B-cell proliferative disorders such as non-Hodgkin lymphoma (diffuse large B cell lymphoma, follicular lymphoma, mantle cell lymphoma or burkitt lymphoma), Waldenstrom macroglobulinemia, plasma cell myeloma, chronic lymphocytic leukemia, lymphoma, or leukemia. These compositions are designed for oral ingestion. The compositions are contained within a capsule such as a standard or sprinkle or in a liquid formulation such as a suspension. In one embodiment, the pharmaceutical composition contains Ibrutinib, a salt, prodrug, or metabolite thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, and magnesium stearate.

Abstract: This disclosure relates to pharmaceutical compositions in the form of a solution for oral delivery. Particularly, the pharmaceutical compositions comprise an active pharmaceutical ingredient, a buffering agent, and water. In some embodiments, the pH of the composition is from about pH 5 to about pH 8. In some embodiments, the active pharmaceutical ingredient is selected from ramipril, solifenacin, vigabatrin, losartan potassium, warfarin, and melatonin.

Abstract: Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an anti-cancer active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the anti-cancer active pharmaceutical ingredient is selected from ibrutinib, nilotinib, dasatinib, sunitinib, sorafenib, erlotinib, and capecitabine.

Abstract: A remote health care apparatus is disclosed that incorporates a drone device and a health kit. The drone device includes one or more communication devices, and the drone device is capable of two-way auditory and visual communication. The health kit is capable of being transported by the drone device and can be detached from the drone device. In one embodiment, the health kit contains one or more medical devices selected from the group consisting of biometric measuring devices, specimen collection devices and lab testing tools.

Abstract: According to a first aspect, there is provided an identity verifier comprising: at least one processor; at least one memory including computer program code; and a communication port coupled to the processor the at least one memory and the computer program code configured to, with the at least one processor, cause the identity verifier at least to: receive, through the communication port, query information to verify an identity provided by a party requesting a financial service; extract a unique identifier of an electronic device from the query information, the electronic device used to request the financial service; calculate a probability of an accuracy of the identity verification by at least determining whether one or more databases contain a record of the unique identifier, the one or more databases storing data used to perform the identity verification; and respond, through the communication port, to the query with the calculated probability.

Abstract: Techniques are disclosed for increasing accessibility of digital content. For instance, a code for the digital content and one or more accessibility guidelines are received. The code is analyzed to identify a violation of an accessibility guideline. The digital content presented in accordance with the code, data indicative of the violation, and an option to correct the violation are displayed on a User Interface (UI). In response to receiving an input indicative of a selection of the option to correct the violation, one or more correction options to correct the violation are provided. In response to a selection of a correction option, the code is altered, based on the selected correction option. The alteration of the code corrects the violation of the accessibility guideline and thereby changes one or more aspects of how the digital content is to be presented.

Abstract: Pharmaceutical compositions comprising oil as a vehicle, a suspending agent, and a surfactant are disclosed to be used in conjunction with active pharmaceutical ingredients which are water soluble or insoluble, or which are sensitive to water but insoluble in oil. Such active pharmaceutical ingredients may include temozolomide, lenalidomide, Oxaliplatin, Cisplatin, Carboplatin, 5-fluorouracil, irinotecan, topotecan, cyclophosphamide, doxorubicin, vincristine, vinblastine, Melphalan, Chlorambucil, Dacarbazine, Daunorubicin, Epirubicin, Mitoxantrone, Etoposide, Teniposide, Azacitidine, Cytarabine, Gemcitabine, vinoralbine, Pemetrexed, a derivative thereof, or a combination thereof. The pharmaceutical compositions may be administered as an oral suspension. Other embodiments are directed towards methods of using and methods of making such formulations.

Abstract: The present invention provides the sterilization of an ophthalmic composition comprising timolol or salt thereof optionally with pharmaceutically acceptable agent(s) wherein the sterilization is achieved through aseptic filtration technique. Further the present invention provides the sterilization process by optimising the process parameters by varying the heating time at a temperature to control the viscosity of the ophthalmic composition of present invention through aseptic filtration technique wherein the filtration is done under aseptic condition through 0.45 ?m clarification pre-filter followed by 0.2? sterilizing grade filter. The process is simple and economical.